Erasca (ERAS) Earnings Date & Reports

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ERAS is expected to report earnings to rise 21.09% to -13 cents per share on August 07

Q2'25

Est.

$-0.13

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.06

Q2'24

Missed

by $0.11

The last earnings report on May 13 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 889.93K shares outstanding, the current market capitalization sits at 364.02M.

View a ticker or compare two or three

Compare

ERAS